Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Alloplex Biotherapeutics

Request full access

Dedicated to exploring the higher order combinatorial space of immunomodulators to develop an effective anti-tumor vaccine

Boston, United StatesFounded 2016Biotech & Life Sciences

About Alloplex Biotherapeutics

Alloplex Biotherapeutics operates in the biotechnology sector, focusing on developing innovative cellular therapies for cancer treatment. The company's core product is the SUPLEXA therapeutic cells, which are reprogrammed rather than genetically engineered to recognize and kill tumor cells. This approach allows for a simple, inexpensive, and reproducible manufacturing process that does not require genetic engineering or feeder cells, making it GMP (Good Manufacturing Practice) compatible. Alloplex serves the oncology market, targeting various types of tumors with its tumor-agnostic platform. The business model revolves around research and development, clinical trials, and eventual commercialization of its cellular therapies. Revenue is generated through partnerships, licensing agreements, and potentially direct sales of its therapeutic products once they receive regulatory approval.

Source: Dealroom company data

At a glance

Status
Operational
Employees
5
Open positions
None listed
Dealroom signal
48.8/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Feb 2023 $25M $100M Undisclosed ↗
EARLY VCEquity / VC Aug 2021 $1M $4M Daewoong Pharmaceutical —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Alloplex Biotherapeutics website traffic

Latest recorded traffic for Alloplex Biotherapeutics is 1.1K monthly website visits, down 15.4% over the last three months. Alloplex Biotherapeutics's team grew 25% over the past year.

Latest monthly visits1.1K 3-month web change-15.4% 1-year team growth+25%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Alloplex Biotherapeutics in the Boston ecosystem

Live from Dealroom

The Alloplex Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Daewoong Pharmaceutical
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States80%
🇰🇷 South Korea20%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Alloplex Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Alloplex Biotherapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.